Finance

Lists
Why is 000590 up 2,55%?
Dive Deeper
000590:SHE
Guhan Pharmaceutical Group Co Ltd
8,84 CN¥
+2,55%
(+0,22) 1D
16-окт., 15:04:51 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000590...
Open
8,81 CN¥
High
9,06 CN¥
Low
8,72 CN¥
Mkt. cap
2,12 млд
Avg. vol.
2,96 млн
Volume
3,98 млн
52-wk high
12,90 CN¥
52-wk low
7,47 CN¥
EPS
-0,20 CN¥
Shares outstanding
239,47 млн
No. of employees
1 миң
Open
8,81 CN¥
High
9,06 CN¥
Low
8,72 CN¥
Mkt. cap
2,12 млд
Avg. vol.
2,96 млн
Volume
3,98 млн
52-wk high
12,90 CN¥
52-wk low
7,47 CN¥
EPS
-0,20 CN¥
Shares outstanding
239,47 млн
No. of employees
1 миң
News stories
From web sources and news partners
About Guhan Pharmaceutical Group Co Ltd
CEO-
Employees1,06 миң
Founded1956
Headquarters-
SectorPharmaceutical industry
Websiteguhan.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
82,38 млн
112,86 млн
71,67 млн
62,51 млн
Cost of goods sold
41,46 млн
68,55 млн
40,99 млн
35,83 млн
Cost of revenue
41,46 млн
68,55 млн
40,99 млн
35,83 млн
Research and development expenses
3,37 млн
2,25 млн
3,63 млн
4,23 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33,15 млн
42,61 млн
32,63 млн
28,80 млн
Operating expense
29,05 млн
56,19 млн
37,07 млн
35,72 млн
Total operating expenses
70,52 млн
124,74 млн
78,06 млн
71,55 млн
Operating income
11,86 млн
-11,89 млн
-6,39 млн
-9,04 млн
Other non operating income
-6,47 млн
-6,19 млн
-29,18 миң
-57,13 миң
EBT including unusual items
2,23 млн
-36,85 млн
-6,68 млн
-6,46 млн
EBT excluding unusual items
4,83 млн
-17,97 млн
-6,80 млн
-8,63 млн
Income tax expense
28,47 миң
-1,84 млн
128,94 миң
1,71 млн
Effective tax rate
1,28%
5,00%
-1,93%
-26,54%
Other operating expenses
-988,48 миң
4,95 млн
810,79 миң
2,59 млн
Net income
2,35 млн
-35,70 млн
-6,81 млн
-8,16 млн
Net profit margin
2,85%
-31,63%
-9,51%
-13,05%
Earnings per share
-
-
-
-
Interest and investment income
193,02 миң
844,37 миң
109,80 миң
899,59 миң
Interest expense
-746,66 миң
-733,66 миң
-491,09 миң
-429,27 миң
Net interest expenses
-553,63 миң
110,71 миң
-381,28 миң
470,32 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
18,35 млн
-4,70 млн
796,96 миң
-1,83 млн
Gain or loss from assets sale
3,44 млн
-2,42 млн
-
-312,94 миң
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору